<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VES</journal-id>
<journal-id journal-id-type="hwp">spves</journal-id>
<journal-id journal-id-type="nlm-ta">Vasc Endovascular Surg</journal-id>
<journal-title>Vascular and Endovascular Surgery</journal-title>
<issn pub-type="ppub">1538-5744</issn>
<issn pub-type="epub">1938-9116</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1538574413493679</article-id>
<article-id pub-id-type="publisher-id">10.1177_1538574413493679</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Low Hemoglobin Concentration Is Associated With Poor Outcome After Peripheral Arterial Surgery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Oshin</surname>
<given-names>O. A.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1538574413493679">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Torella</surname>
<given-names>F.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1538574413493679">1</xref>
<xref ref-type="corresp" rid="corresp1-1538574413493679"/>
</contrib>
</contrib-group>
<aff id="aff1-1538574413493679">
<label>1</label>Liverpool Vascular and Endovascular Service, University Hospital Aintree, Liverpool, United Kingdom</aff>
<author-notes>
<corresp id="corresp1-1538574413493679">F. Torella, Liverpool Vascular and Endovascular Service, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, United Kingdom. Email: <email>f.torella@liverpool.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>47</volume>
<issue>6</issue>
<fpage>449</fpage>
<lpage>453</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<!--CL content="<italic>Vascular and Endovascular Surgery XX&#x0028;X&#x0029;</italic>"-->
<!--CL content="<italic>Oshin and Torella</italic>"-->
<abstract>
<sec>
<title>Objective:</title>
<p>To assess the influence of low hemoglobin (Hb) concentration on major adverse cardiac events (MACE) and mortality in patients undergoing peripheral arterial surgery.</p>
</sec>
<sec>
<title>Methods:</title>
<p>This was a retrospective cohort study of patients undergoing peripheral arterial reconstructive surgery at a tertiary vascular center. Preoperative factors linked with the occurrence of MACE and death on univariate analysis (<italic>P</italic> ≤ .1) were included in a multivariate model to confirm the independent association with the outcome variables.</p>
</sec>
<sec>
<title>Results:</title>
<p> A total of 360 consecutive patients (238 men) with a mean (standard deviation) age of 69 (10.7) years and Hb of 13.0 (2.12) g/dL treated under the care of a single specialist between January 2004 and December 2011 were included in the analysis. Of these, 193 (53.6%) were anemic. In all, 26 (7%) had a postoperative MACE and 18 (5%) died. On multivariate analysis, age &gt; 80 years (odds ratio [OR] = 3; 95% confidence interval [CI] [1.2-7.5]; <italic>P</italic> = .025), renal impairment (OR = 3.2; 95% CI [.99-10.2]; <italic>P</italic> = .053), coronary disease (OR = 3.6; 95% CI [1.5-8.7]; <italic>P</italic> = .005), and low Hb (OR for each 1 g/dL drop below the mean = 1.4 [1.13-1.7]; <italic>P</italic> = .002) were independent risk factors for MACE. Unplanned surgery (OR = 4.5; 95% CI [1.2-16.9]; <italic>P</italic> = .025) and low Hb (OR for each 1 g/dL drop below the mean = 1.5; 95% CI [1.14-1.86]; <italic>P</italic> = .002) were independent risk factors for death.</p>
</sec>
<sec>
<title>Conclusion:</title>
<p> In peripheral arterial surgery, preoperative low Hb is associated with MACE and death. Further investigation is necessary to elucidate whether this relationship is causal. Meanwhile, consideration should be given to treating preoperative anemia as a significant risk factor for adverse outcome in this setting.</p>
</sec>
</abstract>
<kwd-group>
<kwd>anemia</kwd>
<kwd>peripheral arterial disease</kwd>
<kwd>peripheral arterial surgery</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1538574413493679">
<title>Introduction</title>
<p>Anemia is commonly encountered before major surgery and is an independent risk factor for poor outcome.<sup>
<xref ref-type="bibr" rid="bibr1-1538574413493679">1</xref><xref ref-type="bibr" rid="bibr2-1538574413493679"/>–<xref ref-type="bibr" rid="bibr3-1538574413493679">3</xref>
</sup> Patients with peripheral arterial disease (PAD) are prone to anemia of chronic disease. This is likely a consequence of repeated infection and the inflammatory response associated with critical limb ischemia,<sup>
<xref ref-type="bibr" rid="bibr4-1538574413493679">4</xref>
</sup> while iron-deficiency anemia may reflect poor nutrition in others.</p>
<p>The relationship between anemia and postoperative outcome is well documented in patients undergoing major cardiac, orthopedic, and gastrointestinal surgery<sup>
<xref ref-type="bibr" rid="bibr5-1538574413493679">5</xref><xref ref-type="bibr" rid="bibr6-1538574413493679"/><xref ref-type="bibr" rid="bibr7-1538574413493679"/>–<xref ref-type="bibr" rid="bibr8-1538574413493679">8</xref>
</sup>; however, there is a paucity of published data specifically addressing the influence of low hemoglobin (Hb) on clinical outcome in patients undergoing peripheral arterial surgery (PAS). Most patients undergoing PAS have PAD and are thus prone to perioperative cardiac events due to the high prevalence of coronary atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr9-1538574413493679">9</xref>
</sup> Furthermore it has been demonstrated that anemia may worsen prognosis after such events.<sup>
<xref ref-type="bibr" rid="bibr10-1538574413493679">10</xref>
</sup> The aim of this study was to quantify the impact, if any, of preoperative Hb concentration on the incidence of major adverse coronary events (MACE) and mortality in patients undergoing PAS.</p>
</sec>
<sec id="section2-1538574413493679" sec-type="methods">
<title>Methods</title>
<p>This was a retrospective cohort study on consecutive patients undergoing peripheral arterial reconstructive surgery between January 2004 and December 2011. Patients scheduled for surgery in order to treat either occlusive or aneurysmal disease were eligible for inclusion. Exclusion criteria were emergency surgery (&lt;12 hours from admission to hospital), nonreconstructive procedures (ie embolectomy), amputation, surgery for aortoiliac aneurysms, surgery to create vascular access, endovascular procedures, and surgery for trauma. All procedures were performed either by or under the supervision of a single surgeon in a tertiary vascular unit serving a predominantly deprived population. Demographic and procedure-specific data were collected preoperatively and entered into a dedicated database. For the purposes of this study, anemia was determined by preoperative Hb values below the normal reference range of our hematology laboratory (&lt;14 g/dL and &lt;12 g/dL in men and women, respectively).</p>
<p>The primary end points were MACE and all-cause mortality at 30 days or during the patients’ hospital stay (whichever the longest). MACE was defined as one or more of the following: myocardial infarction (typical chest pain and/or ischemic ST segment changes on electrocardiography with a significant troponin T or I rise [&gt;14 ng/L and &gt;.1 ng/L, respectively]), coronary revascularization, sudden death, and left ventricular failure (independent clinical diagnosis and/or pulmonary congestion on chest radiography requiring acute treatment with diuretics, nitrates, or inotropes).<sup>
<xref ref-type="bibr" rid="bibr11-1538574413493679">11</xref>
</sup> Except for selected patients, troponin assays were performed only when there was clinical suspicion of myocardial ischemia.</p>
<p>In order to identify preoperative predictors of outcome, specific variables were initially tested by univariate analysis. Potential associations with MACE and death on univariate tests were then entered into a multivariate model to identify independent associations. The variables tested were selected a priori. For MACE, these were the Eagle criteria (age, coronary disease, nondiet-controlled diabetes, Q waves on electrocardiography, but not ventricular ectopics, since this feature was not routinely sought in our patients),<sup>
<xref ref-type="bibr" rid="bibr12-1538574413493679">12</xref>
</sup> revised cardiac risk index variables (coronary disease, congestive cardiac failure, cerebrovascular disease, diabetes on insulin, preoperative creatinine &gt; 177 μmol/L, high-risk surgery—in this cohort, defined as any operation involving the abdominal aorta),<sup>
<xref ref-type="bibr" rid="bibr13-1538574413493679">13</xref>
</sup> unplanned surgery (defined as any surgery performed during an unplanned admission), use of antiplatelet or anticoagulant therapy, use of statins,<sup>
<xref ref-type="bibr" rid="bibr14-1538574413493679">14</xref>
</sup> and use of β-blockers.<sup>
<xref ref-type="bibr" rid="bibr15-1538574413493679">15</xref>
</sup> Age was categorized as &gt; or ≤80 (instead of &gt;70, as in the Eagle criteria), since this cutoff was previously found to be relevant in our patients.<sup>
<xref ref-type="bibr" rid="bibr16-1538574413493679">16</xref>
</sup> For death, we added American Society of Anesthesiologists (ASA) score,<sup>
<xref ref-type="bibr" rid="bibr17-1538574413493679">17</xref>
</sup> sex,<sup>
<xref ref-type="bibr" rid="bibr18-1538574413493679">18</xref>
</sup> and respiratory disease<sup>
<xref ref-type="bibr" rid="bibr19-1538574413493679">19</xref>
</sup> to the above-mentioned variables.</p>
<sec id="section3-1538574413493679">
<title>Statistical Analysis</title>
<p>Continuous variables were described with mean and standard deviation (SD) if normally distributed and median and quartiles (interquartile range [IQR]) if skewed. Comparisons between the groups were made using the unpaired <italic>t</italic> test and the Mann-Whitney <italic>U</italic> test, respectively. Categorical variables were compared with the chi-square test, with a continuity correction for 2 × 2 tables or with the Fisher exact test when cell numbers were low. Variables potentially associated with the outcome measures on univariate tests (<italic>P</italic> ≤ .1) were entered into a logistic regression model to establish whether preoperative Hb maintained an independent association with the outcome measures. For the purposes of this analysis, Hb was used as a continuous variable. All the analyses were performed on dedicated statistical software (PASW 18, Chicago, Illinois).</p>
</sec>
</sec>
<sec id="section4-1538574413493679">
<title>Results</title>
<p>A total of 360 patients (238 men) with a mean age (SD) of 69 (10.7) years were eligible for the analysis. Their physical status was typical of a population undergoing arterial surgery (<xref ref-type="table" rid="table1-1538574413493679">Tables 1</xref> and <xref ref-type="table" rid="table2-1538574413493679">2</xref>). Tissue loss was the commonest indication for surgery (<xref ref-type="table" rid="table3-1538574413493679">Table 3</xref>) and 39.2% (n = 141) had undergone some form of vascular surgical intervention prior to their surgery. Most operations were infrainguinal reconstructions (262); 39 were extra-anatomical bypasses, 57 were suprainguinal reconstructions, and 2 combined supra and infrainguinal reconstructions. Autologous vein was the bypass conduit in 51.3% (n = 179) of the patients, with prosthetic (43.8%, n = 153), composite (4.5%, n = 16), and arterial homograft (0.3%, n = 1) also being used. In 11 patients, no conduit was used, as only an endarterectomy was performed.</p>
<table-wrap id="table1-1538574413493679" position="float">
<label>Table 1.</label>
<caption>
<p>Comorbidity, Medical Therapy, and Smoking Habits.</p>
</caption>
<graphic alternate-form-of="table1-1538574413493679" xlink:href="10.1177_1538574413493679-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Coronary disease</td>
<td>126 (35)</td>
</tr>
<tr>
<td>Left ventricular failure</td>
<td>38 (10.6)</td>
</tr>
<tr>
<td>Atrial fibrillation</td>
<td>45 (12.5)</td>
</tr>
<tr>
<td>Respiratory disease</td>
<td>99 (27.5)</td>
</tr>
<tr>
<td>Diabetes</td>
<td>69 (19.2)</td>
</tr>
<tr>
<td> Diet controlled</td>
<td>6 (1.7)</td>
</tr>
<tr>
<td> Oral agents</td>
<td>46 (12.8)</td>
</tr>
<tr>
<td> Insulin</td>
<td>17 (4.7)</td>
</tr>
<tr>
<td>Hypertension</td>
<td>232 (64.4)</td>
</tr>
<tr>
<td>Cerebrovascular disease</td>
<td>75 (20.9)</td>
</tr>
<tr>
<td>Renal impairment</td>
<td>21 (5.8)</td>
</tr>
<tr>
<td colspan="2">Smoking status</td>
</tr>
<tr>
<td> Never</td>
<td>30 (8.3)</td>
</tr>
<tr>
<td> Ex</td>
<td>167 (46.4)</td>
</tr>
<tr>
<td> Current</td>
<td>163 (45.3)</td>
</tr>
<tr>
<td>Antiplatelet therapy</td>
<td>313 (86.9)</td>
</tr>
<tr>
<td>Anticoagulant therapy</td>
<td>16 (4.4)</td>
</tr>
<tr>
<td>Statin therapy</td>
<td>319 (88.6)</td>
</tr>
<tr>
<td>β-Blocker therapy</td>
<td>195 (54.2)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table2-1538574413493679" position="float">
<label>Table 2.</label>
<caption>
<p>Risk Scores.</p>
</caption>
<graphic alternate-form-of="table2-1538574413493679" xlink:href="10.1177_1538574413493679-table2.tif"/>
<table>
<thead>
<tr>
<th>Risk Score</th>
<th>n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2">Eagle criteria</td>
</tr>
<tr>
<td> 0</td>
<td>110 (30.6)</td>
</tr>
<tr>
<td> 1</td>
<td>137 (38.1)</td>
</tr>
<tr>
<td> 2</td>
<td>82 (22.8)</td>
</tr>
<tr>
<td> 3</td>
<td>27 (7.5)</td>
</tr>
<tr>
<td> 4</td>
<td>4 (1.1)</td>
</tr>
<tr>
<td colspan="2">Revised cardiac index</td>
</tr>
<tr>
<td> 0</td>
<td>160 (44.4)</td>
</tr>
<tr>
<td> 1</td>
<td>123 (34.2)</td>
</tr>
<tr>
<td> 2</td>
<td>57 (15.8)</td>
</tr>
<tr>
<td> 3</td>
<td>14 (3.9)</td>
</tr>
<tr>
<td> 4</td>
<td>6 (1.7)</td>
</tr>
<tr>
<td colspan="2">ASA grade</td>
</tr>
<tr>
<td> I</td>
<td>4 (1.1)</td>
</tr>
<tr>
<td> II</td>
<td>99 (27.5)</td>
</tr>
<tr>
<td> III</td>
<td>219 (60.9)</td>
</tr>
<tr>
<td> IV</td>
<td>38 (10.6)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1538574413493679">
<p>Abbreviation: ASA, American Society of Anesthesiologists.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-1538574413493679" position="float">
<label>Table 3.</label>
<caption>
<p>Indications for Surgery.</p>
</caption>
<graphic alternate-form-of="table3-1538574413493679" xlink:href="10.1177_1538574413493679-table3.tif"/>
<table>
<thead>
<tr>
<th>Indication</th>
<th>n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Claudication</td>
<td>81 (22.5)</td>
</tr>
<tr>
<td>Rest pain</td>
<td>92 (25.6)</td>
</tr>
<tr>
<td>Tissue loss</td>
<td>118 (32.8)</td>
</tr>
<tr>
<td>Aneurysm</td>
<td>20 (5.6)</td>
</tr>
<tr>
<td>Acute ischemia</td>
<td>33 (9.2)</td>
</tr>
<tr>
<td>Graft infection</td>
<td>10 (2.8)</td>
</tr>
<tr>
<td>Failing graft</td>
<td>6 (1.7)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In all, 147 patients (40.8%) had a postoperative complication, the details of which are given in <xref ref-type="table" rid="table4-1538574413493679">Table 4</xref>. In all, 26 (7%) had a postoperative MACE and 18 (5%) died.</p>
<table-wrap id="table4-1538574413493679" position="float">
<label>Table 4.</label>
<caption>
<p>Complications.</p>
</caption>
<graphic alternate-form-of="table4-1538574413493679" xlink:href="10.1177_1538574413493679-table4.tif"/>
<table>
<thead>
<tr>
<th>Outcome</th>
<th>n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Deaths</td>
<td>18 (5)</td>
</tr>
<tr>
<td>Limb loss</td>
<td>13 (3.6)</td>
</tr>
<tr>
<td>MACE</td>
<td>26 (7.2)</td>
</tr>
<tr>
<td> Myocardial infarction</td>
<td>24 (6.7)</td>
</tr>
<tr>
<td> Left ventricular failure</td>
<td>16 (4.4)</td>
</tr>
<tr>
<td>Respiratory failure</td>
<td>8 (2.2)</td>
</tr>
<tr>
<td>Noninfective wound complications</td>
<td>25 (6.9)</td>
</tr>
<tr>
<td>Renal failure</td>
<td>1 (0.3)</td>
</tr>
<tr>
<td>Venous thromboembolism</td>
<td>1 (0.3)</td>
</tr>
<tr>
<td>Hemorrhage</td>
<td>14 (3.9)</td>
</tr>
<tr>
<td>Stroke</td>
<td>6 (1.7)</td>
</tr>
<tr>
<td>GI bleed</td>
<td>3 (0.8)</td>
</tr>
<tr>
<td>Graft thrombosis</td>
<td>29 (8.1)</td>
</tr>
<tr>
<td colspan="2">Infection</td>
</tr>
<tr>
<td> Wound</td>
<td>33 (9.2)</td>
</tr>
<tr>
<td> Respiratory</td>
<td>21 (5.9)</td>
</tr>
<tr>
<td> Urinary</td>
<td>7 (2.1)</td>
</tr>
<tr>
<td> Graft</td>
<td>3 (0.8)</td>
</tr>
<tr>
<td> Gastrointestinal</td>
<td>3 (0.8)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1538574413493679">
<p>Abbreviation: MACE, major adverse cardiac events.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The mean (SD) preoperative Hb was 13.0 (2.12) g/dL. Some 193 patients (53.6%) were anemic according to our definitions of whom 4.2% (n = 15) required intraoperative transfusion. MACE was common in patients with anemia (21 of 193 vs 5 of 167, <italic>P</italic> = .007) as was postoperative death (16/193 vs 2/167, <italic>P</italic> = .005). <xref ref-type="fig" rid="fig1-1538574413493679">Figure 1</xref> shows the incidence of MACE (A) and death (B) stratified by preoperative Hb concentration; Hb was significantly lower in patients who had a MACE, at a median (IQR) 11.1 (10.4-12.8) g/dL in comparison to uncomplicated cases, 13.3 (11.8-14.5) g/dL (<italic>P</italic> &lt; .001). On univariate analysis, age, cerebrovascular disease, coronary disease, renal impairment (creatinine &gt; 177 mol/L), left ventricular failure, and the use of β-blockers were also associated with MACE (<xref ref-type="table" rid="table5-1538574413493679">Table 5</xref>). Preoperative Hb was also significantly lower in patients who died at a median (IQR) of 11.3 (9.4-13.2) g/dL in comparison to survivors, 13.2 (11.7-14.5) g/dL (<italic>P</italic> &lt; .001). Other possible associations on univariate analysis were age, renal impairment, unplanned surgery, and ASA grade (<xref ref-type="table" rid="table5-1538574413493679">Table 5</xref>).</p>
<fig id="fig1-1538574413493679" position="float">
<label>Figure 1.</label>
<caption>
<p>A, Major adverse cardiac events stratified by hemoglobin (Hb) concentration. B, Mortality stratified by Hb concentration.</p>
</caption>
<graphic xlink:href="10.1177_1538574413493679-fig1.tif"/>
</fig>
<table-wrap id="table5-1538574413493679" position="float">
<label>Table 5.</label>
<caption>
<p>Potential Predictors of Poor Outcome (Univariate Analysis).</p>
</caption>
<graphic alternate-form-of="table5-1538574413493679" xlink:href="10.1177_1538574413493679-table5.tif"/>
<table>
<thead>
<tr>
<td>(a) MACE</td>
<td align="center">n</td>
<td>n with MACE</td>
<td align="center">%</td>
<td align="center">
<italic>P</italic> Value</td>
</tr>
</thead>
<tbody>
<tr>
<td>Age &gt; 80</td>
<td>59</td>
<td>9</td>
<td>15.2</td>
<td>.025</td>
</tr>
<tr>
<td>Cerebrovascular disease</td>
<td>75</td>
<td>10</td>
<td>13.3</td>
<td>.041</td>
</tr>
<tr>
<td>Coronary disease</td>
<td>126</td>
<td>16</td>
<td>12.7</td>
<td>.006</td>
</tr>
<tr>
<td>Renal impairment<sup>a</sup>
</td>
<td>21</td>
<td>5</td>
<td>23.8</td>
<td>.012</td>
</tr>
<tr>
<td>LVF</td>
<td>38</td>
<td>6</td>
<td>15.8</td>
<td>.043</td>
</tr>
<tr>
<td>β-Blocker use</td>
<td>195</td>
<td>20</td>
<td>10.3</td>
<td>.028</td>
</tr>
<tr>
<td>Unplanned surgery</td>
<td>152</td>
<td>18</td>
<td>11.8</td>
<td>.007</td>
</tr>
<tr>
<td>(b) Death</td>
<td>n</td>
<td>Deaths</td>
<td align="center">%</td>
<td align="center">
<italic>P</italic> Value</td>
</tr>
<tr>
<td>Age &gt; 80</td>
<td>59</td>
<td>6</td>
<td>10.2</td>
<td>.096</td>
</tr>
<tr>
<td>Renal impairment</td>
<td>21</td>
<td>3</td>
<td>14.3</td>
<td>.079</td>
</tr>
<tr>
<td>Unplanned surgery</td>
<td>152</td>
<td>15</td>
<td>9.9</td>
<td>.001</td>
</tr>
<tr>
<td>ASA grade</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>.009</td>
</tr>
<tr>
<td> I</td>
<td>4</td>
<td>0</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> II</td>
<td>99</td>
<td>2</td>
<td>2</td>
<td>
</td>
</tr>
<tr>
<td> III</td>
<td>219</td>
<td>10</td>
<td>4.6</td>
<td>
</td>
</tr>
<tr>
<td> IV</td>
<td>38</td>
<td>6</td>
<td>15.8</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1538574413493679">
<p>Abbreviations: ASA, American Society of Anesthesiologists; LVF, left ventricular failure; MACE, major adverse cardiac events.</p>
</fn>
<fn id="table-fn4-1538574413493679">
<p>
<sup>a</sup> Creatinine &gt;177 μmol/L.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Multivariate analysis showed that, after correction for potential confounding variables, low Hb maintained an independent association with MACE (odds ratio [OR] for each 1 g/dL drop below the mean = 1.4 [1.13-1.7]; <italic>P</italic> = .002) and death (OR for each 1 g/dL drop below the mean = 1.5; 95% confidence interval [CI; 1.14-1.86]; <italic>P</italic> = .002). Age &gt;80 years (OR = 3; 95% CI [1.2-7.5]; <italic>P</italic> = .025), renal impairment (OR = 3.2; 95% CI [.99-10.2]; <italic>P</italic> = .053), coronary disease (OR = 3.6; 95% CI [1.5-8.7]; <italic>P</italic> = .005) were also independently associated with MACE, while unplanned surgery (OR = 4.5; 95% CI [1.2-16.9]; <italic>P</italic> = .025) was associated with postoperative death.</p>
</sec>
<sec id="section5-1538574413493679">
<title>Discussion</title>
<p>We showed that preoperative anemia predicts MACE and death after peripheral arterial surgery even after adjustment for individual patients’ comorbid conditions. These results are in keeping with the previous publications on patients undergoing cardiac, orthopedic, and gastrointestinal surgery.<sup>
<xref ref-type="bibr" rid="bibr1-1538574413493679">1</xref><xref ref-type="bibr" rid="bibr2-1538574413493679"/><xref ref-type="bibr" rid="bibr3-1538574413493679"/><xref ref-type="bibr" rid="bibr4-1538574413493679"/>–<xref ref-type="bibr" rid="bibr5-1538574413493679">5</xref>
</sup>
</p>
<p>Anemia is a risk factor for MACE and, potentially, perioperative mortality because it reduces physiologic compensatory capacity in patients with low cardiac reserve and compounds compromised oxygen delivery in individuals with coronary artery disease.<sup>
<xref ref-type="bibr" rid="bibr20-1538574413493679">20</xref>
</sup> Indeed in this particular cohort of patients, coronary disease is a frequent finding with reported prevalence ranging from 14% to 90%.<sup>
<xref ref-type="bibr" rid="bibr9-1538574413493679">9</xref>
</sup> Moreover, up to 71% of patients with PAD have been found to have subclinical coronary disease.<sup>
<xref ref-type="bibr" rid="bibr21-1538574413493679">21</xref>–<xref ref-type="bibr" rid="bibr22-1538574413493679">22</xref>
</sup> In addition, anemia may be caused by malnutrition, iron deficiency, bone marrow depression, and increased circulating levels of proinflammatory cytokines as well as being a common and interrelated finding in patients with diabetes<sup>
<xref ref-type="bibr" rid="bibr23-1538574413493679">23</xref>
</sup> and renal dysfunction.<sup>
<xref ref-type="bibr" rid="bibr24-1538574413493679">24</xref>
</sup> It is therefore difficult to ascertain whether anemia is a causative factor for the clinical outcomes reported in this study or simply a reflection of the physiological conditions of this cohort of patients and perhaps the burden of atherosclerotic disease.</p>
<p>Establishing the existence of a causal relationship between anemia and adverse clinical outcome is important, since this knowledge will guide the most effective therapy for preoperative anemia. Addressing anemia effectively assumes a causal link between anemia and poor outcome. However, there is little evidence for the use of intravenous iron in this setting,<sup>
<xref ref-type="bibr" rid="bibr25-1538574413493679">25</xref>
</sup> and while there is more encouraging evidence for the use of erythropoietin,<sup>
<xref ref-type="bibr" rid="bibr26-1538574413493679">26</xref>
</sup> its use can also result in a higher incidence of thrombotic events<sup>
<xref ref-type="bibr" rid="bibr27-1538574413493679">27</xref>
</sup> and as such may not be beneficial to patients undergoing vascular procedure for PAS. Blood transfusion is another option for correcting preoperative anemia but has its attendant risks.<sup>
<xref ref-type="bibr" rid="bibr28-1538574413493679">28</xref><xref ref-type="bibr" rid="bibr29-1538574413493679"/>–<xref ref-type="bibr" rid="bibr30-1538574413493679">30</xref>
</sup> Although this risk is minimal with modern processing techniques, it often outweighs the potential benefit of blood transfusion in normovolemic surgical patients.<sup>
<xref ref-type="bibr" rid="bibr31-1538574413493679">31</xref>
</sup> Some studies have shown a trend toward lower mortality and morbidity rates when a lower threshold for transfusion is used<sup>
<xref ref-type="bibr" rid="bibr32-1538574413493679">32</xref>
</sup>; however, no benefit has been shown in patients with preexisting coronary disease.<sup>
<xref ref-type="bibr" rid="bibr33-1538574413493679">33</xref>,<xref ref-type="bibr" rid="bibr34-1538574413493679">34</xref>
</sup>
</p>
<p>A recent study has shown that anemia (in particular iron deficiency) is more prevalent in patients with critical ischemia than those with intermittent claudication<sup>
<xref ref-type="bibr" rid="bibr35-1538574413493679">35</xref>
</sup> and perhaps supports the notion that preoperative anemia is a marker of poor physiological conditions. Furthermore patients with critical ischemia also have chronic inflammation and gangrene and are therefore more prone to anemia of chronic disease.<sup>
<xref ref-type="bibr" rid="bibr36-1538574413493679">36</xref>
</sup> This may in part explain the association between unplanned surgery and increased mortality demonstrated in this study, since this group of patients would be expected to have more severe PAD.</p>
<p>Although it is possible to investigate and address iron-deficiency anemia preoperatively, it should be noted that many of our patients required urgent intervention, therefore, the time available for assessment and correction of anemia may have been limited. In such instances awareness of preoperative anemia may be more useful as a risk stratification tool and perhaps guide the choice of intervention in cases of equipoise between conventional surgery and less invasive endovascular therapies.</p>
<p>This study cannot determine whether a causal link exists between anemia and adverse clinical outcome; therefore, further studies are necessary. Furthermore, investigation and correction of anemia may be impossible or impractical for many patients and may not improve outcome if low Hb is simply a marker of poor physiological status. As such, we suggest that in potential candidates for PAD surgery the presence of anemia should be considered a marker of risk in the preoperative decision-making process and during patients’ counseling/consent. In particular cases, it may add weight to a decision to offer conservative or percutaneous treatment instead of surgery.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1538574413493679">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1538574413493679">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1538574413493679">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunne</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Malone</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tracy</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Gannon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>LM</given-names>
</name>
</person-group>. <article-title>Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery</article-title>. <source>J Surg Res</source>. <year>2002</year>;<volume>102</volume>(<issue>2</issue>):<fpage>237</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr2-1538574413493679">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napolitano</surname>
<given-names>LM</given-names>
</name>
</person-group>. <article-title>Perioperative anemia</article-title>. <source>Surg Clin North Am</source>. <year>2005</year>;<volume>85</volume>(<issue>6</issue>):<fpage>1215</fpage>–<lpage>1227</lpage>.</citation>
</ref>
<ref id="bibr3-1538574413493679">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>116</volume>(<issue>5</issue>):<fpage>471</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr4-1538574413493679">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>B</given-names>
</name>
<name>
<surname>MacSweeney</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Recognising anaemia and malnutrition in vascular patients with critical limb ischaemia</article-title>. <source>Ann R Coll Surg Engl</source>. <year>2010</year>;<volume>92</volume>(<issue>6</issue>):<fpage>495</fpage>–<lpage>498</lpage>.</citation>
</ref>
<ref id="bibr5-1538574413493679">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Musallam</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Tamim</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study</article-title>. <source>Lancet</source>. <year>2011</year>;<volume>378</volume>(<issue>9800</issue>):<fpage>1396</fpage>–<lpage>1407</lpage>.</citation>
</ref>
<ref id="bibr6-1538574413493679">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karkouti</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wijeysundera</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Beattie</surname>
<given-names>WS</given-names>
</name>
</person-group>. <article-title>Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study</article-title>. <source>Circulation</source>. <year>2008</year>;<volume>117</volume>(<issue>4</issue>):<fpage>478</fpage>–<lpage>484</lpage>.</citation>
</ref>
<ref id="bibr7-1538574413493679">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulier</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Anemia and morbidity and mortality in coronary bypass surgery</article-title>. <source>Curr Opin Anaesthesiol</source>. <year>2007</year>;<volume>20</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr8-1538574413493679">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruson</surname>
<given-names>KI</given-names>
</name>
<name>
<surname>Aharonoff</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Egol</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Zuckerman</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Koval</surname>
<given-names>KJ</given-names>
</name>
</person-group>. <article-title>The relationship between admission hemoglobin level and outcome after hip fracture</article-title>. <source>J Orthop Trauma</source>. <year>2002</year>;<volume>16</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr9-1538574413493679">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golomb</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Criqui</surname>
<given-names>MH</given-names>
</name>
</person-group>. <article-title>Peripheral arterial disease: morbidity and mortality implications</article-title>. <source>Circulation</source>. <year>2006</year>;<volume>114</volume>(<issue>7</issue>):<fpage>688</fpage>–<lpage>699</lpage>.</citation>
</ref>
<ref id="bibr10-1538574413493679">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Anaemia and prognosis in acute coronary syndromes: a systematic review and meta-analysis</article-title>. <source>J Int Med Res</source>. <year>2012</year>;<volume>40</volume>(<issue>1</issue>):<fpage>43</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr11-1538574413493679">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welten</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>O</given-names>
</name>
<name>
<surname>van Domburg</surname>
<given-names>RT</given-names>
</name>
<etal/>
</person-group>. <article-title>The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2007</year>;<volume>34</volume>(<issue>6</issue>):<fpage>632</fpage>–<lpage>638</lpage>.</citation>
</ref>
<ref id="bibr12-1538574413493679">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eagle</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Coley</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Newell</surname>
<given-names>JB</given-names>
</name>
<etal/>
</person-group>. <article-title>Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery</article-title>. <source>Ann Intern Med</source>. <year>1989</year>;<volume>110</volume>(<issue>11</issue>):<fpage>859</fpage>–<lpage>866</lpage>.</citation>
</ref>
<ref id="bibr13-1538574413493679">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>TH</given-names>
</name>
<name>
<surname> Marcantonio</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Mangione</surname>
<given-names>CM</given-names>
</name>
<etal/>
</person-group>. <article-title>Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery</article-title>. <source>Circulation</source>. <year>1999</year>;<volume>100</volume>(<issue>10</issue>):<fpage>1043</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr14-1538574413493679">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schouten</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Boersma</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hoeks</surname>
<given-names>SE</given-names>
</name>
<etal/>
</person-group>. <article-title>Fluvastatin and perioperative events in patients undergoing vascular surgery</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>361</volume>(<issue>10</issue>):<fpage>980</fpage>–<lpage>989</lpage>.</citation>
</ref>
<ref id="bibr15-1538574413493679">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devereaux</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yusuf</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>371</volume>(<issue>9627</issue>):<fpage>1839</fpage>–<lpage>1847</lpage>.</citation>
</ref>
<ref id="bibr16-1538574413493679">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parmar</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Torella</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Prediction of major adverse cardiac events in vascular surgery: are cardiac risk scores of any practical value?</article-title> <source>Vasc Endovascular Surg</source>. <year>2010</year>;<volume>44</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr17-1538574413493679">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dripps</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Lamont</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eckenhoff</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>The role of anesthesia in surgical mortality</article-title>. <source>JAMA</source>. <year>1961</year>;<volume>178</volume>:<fpage>261</fpage>–<lpage>266</lpage>.</citation>
</ref>
<ref id="bibr18-1538574413493679">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egorova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vouyouka</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Quin</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of gender-related differences in lower extremity peripheral arterial disease.</article-title> <source>J Vasc Surg</source>. <year>2010</year>;<volume>51</volume>(<issue>2</issue>):<fpage>372 e1</fpage>–<lpage>378 e1</lpage>.</citation>
</ref>
<ref id="bibr19-1538574413493679">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brady</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Fowkes</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Greenhalgh</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Ruckley</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>SG</given-names>
</name>
</person-group>. <article-title>Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants</article-title>. <source>Br J Surg</source>. <year>2000</year>;<volume>87</volume>(<issue>6</issue>):<fpage>742</fpage>–<lpage>749</lpage>.</citation>
</ref>
<ref id="bibr20-1538574413493679">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunkelgrun</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoeks</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Welten</surname>
<given-names>GM</given-names>
</name>
<etal/>
</person-group>. <article-title>Anemia as an independent predictor of perioperative and long-term cardiovascular outcome in patients scheduled for elective vascular surgery</article-title>. <source>Am J Cardiol</source>. <year>2008</year>;<volume>101</volume>(<issue>8</issue>):<fpage>1196</fpage>–<lpage>1200</lpage>.</citation>
</ref>
<ref id="bibr21-1538574413493679">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fowkes</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Housley</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cawood</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Macintyre</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Ruckley</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Prescott</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population</article-title>. <source>Int J Epidemiol</source>. <year>1991</year>;<volume>20</volume>(<issue>2</issue>):<fpage>384</fpage>–<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr22-1538574413493679">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ness</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aronow</surname>
<given-names>WS.</given-names>
</name>
</person-group> <article-title>Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice.</article-title> <source>J Am Geriatr Soc</source>. <year>1999</year>;<volume>47</volume>(<issue>10</issue>):<fpage>1255</fpage>–<lpage>1256</lpage>.</citation>
</ref>
<ref id="bibr23-1538574413493679">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>MacIsaac</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Tsalamandris</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Power</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jerums</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Unrecognized anemia in patients with diabetes: a cross-sectional survey</article-title>. <source>Diabetes Care</source>. <year>2003</year>;<volume>26</volume>(<issue>4</issue>):<fpage>1164</fpage>–<lpage>1169</lpage>.</citation>
</ref>
<ref id="bibr24-1538574413493679">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langston</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Presley</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Flanders</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>McClellan</surname>
<given-names>WM</given-names>
</name>
</person-group>. <article-title>Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction</article-title>. <source>Kidney Int</source>. <year>2003</year>;<volume>64</volume>(<issue>4</issue>):<fpage>1398</fpage>–<lpage>1405</lpage>.</citation>
</ref>
<ref id="bibr25-1538574413493679">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beris</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia-Erce</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Maniatis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van der Linden</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Perioperative anaemia management: consensus statement on the role of intravenous iron</article-title>. <source>Br J Anaesth</source>. <year>2008</year>;<volume>100</volume>(<issue>5</issue>):<fpage>599</fpage>–<lpage>604</lpage>.</citation>
</ref>
<ref id="bibr26-1538574413493679">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corwin</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Gettinger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fabian</surname>
<given-names>TC</given-names>
</name>
<etal/>
</person-group>. <article-title>Efficacy and safety of epoetin alfa in critically ill patients</article-title>. <source>N Engl J Med</source>. <year>2007</year>;<volume>357</volume>(<issue>10</issue>):<fpage>965</fpage>–<lpage>976</lpage>.</citation>
</ref>
<ref id="bibr27-1538574413493679">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hemmelgarn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reiman</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis</article-title>. <source>CMAJ</source>. <year>2009</year>;<volume>180</volume>(<issue>11</issue>):<fpage>E62</fpage>–<lpage>E71</lpage>.</citation>
</ref>
<ref id="bibr28-1538574413493679">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corwin</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Gettinger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pearl</surname>
<given-names>RG</given-names>
</name>
<etal/>
</person-group>. <article-title>The CRIT Study: anemia and blood transfusion in the critically ill—current clinical practice in the United States</article-title>. <source>Crit Care Med</source>. <year>2004</year>;<volume>32</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr29-1538574413493679">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Reinhart</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Anemia and blood transfusion in critically ill patients</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>(<issue>12</issue>):<fpage>1499</fpage>–<lpage>1507</lpage>.</citation>
</ref>
<ref id="bibr30-1538574413493679">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bursi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Barbieri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Politi</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery</article-title>. <source>Eu J Vasc Endovasc Surg</source>. <year>2009</year>;<volume>37</volume>(<issue>3</issue>):<fpage>311</fpage>–<lpage>318</lpage>.</citation>
</ref>
<ref id="bibr31-1538574413493679">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marik</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Corwin</surname>
<given-names>HL</given-names>
</name>
</person-group>. <article-title>Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature</article-title>. <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>(<issue>9</issue>):<fpage>2667</fpage>–<lpage>2674</lpage>.</citation>
</ref>
<ref id="bibr32-1538574413493679">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Anemia in the preoperative patient</article-title>. <source>Med Clin North Am</source>. <year>2009</year>;<volume>93</volume>(<issue>5</issue>):<fpage>1095</fpage>–<lpage>1104</lpage>.</citation>
</ref>
<ref id="bibr33-1538574413493679">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebert</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Blajchman</surname>
<given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.</article-title> <source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>(<issue>6</issue>):<fpage>409</fpage>–<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr34-1538574413493679">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Terrin</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Noveck</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Liberal or restrictive transfusion in high-risk patients after hip surgery</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>365</volume>(<issue>26</issue>):<fpage>2453</fpage>–<lpage>2462</lpage>.</citation>
</ref>
<ref id="bibr35-1538574413493679">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vega de Ceniga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bravo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Izagirre</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Anaemia, iron and vitamin deficits in patients with peripheral arterial disease</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2011</year>;<volume>41</volume>(<issue>6</issue>):<fpage>828</fpage>–<lpage>830</lpage>.</citation>
</ref>
<ref id="bibr36-1538574413493679">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beard</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>ABC of arterial and venous disease: chronic lower limb ischemia</article-title>. <source>BMJ</source>. <year>2000</year>;<volume>320</volume>(<issue>7238</issue>):<fpage>854</fpage>–<lpage>857</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>